There is very nice article in The Atlantic by James Heathers, one reminding us of the dangers of accepting as gospel medical publication results due to their very variable quality (or lack thereof).  This especially applies to articles on COVID-19 appearing in the midst of a pandemic, many of which are flawed.  Ivermectin as a treatment for COVID is his principle example.

Evaluating the quality of a research paper remains an important exercise.